SightfileU.S. market data from official filings

EDITAS MEDICINE INC (EDIT)

Name: EDITAS MEDICINE INC (EDIT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001650664 · EDGAR filings · Updated 2026-07-21

EDITAS MEDICINE INC (EDIT) has reported institutional ownership of 52.9%, with 205 institutional managers holding positions valued at $127.5M per the latest 13F reporting period.

Institutional ownership

52.9%

Institutional managers

205

Reported 13F value

$127.5M

Insider activity

14 trans.

−$88.2K net selling

Latest updates

2026-07-21 — Notice of proposed sale filed (Form 144)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EDITAS MEDICINE INC has 205 institutional holders and institutional ownership of 52.9%.

Insider activity

Insiders reported 14 transactions (0 buys, 14 sells) across 3 reporting insiders, with a net reported value of −$88.2K.

Related companies

VOYAGER THERAPEUTICS INC (VYGR) · QUANTERIX CORP (QTRX) · INNOVAGE HLDG CORP (INNV) · HERON THERAPEUTICS INC (HRTX) · MACROGENICS INC (MGNX) · CRONOS GROUP INC (CRON)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.